Short Description of Business Linahert D5/10 Tablet is a combination medication designed for Type 2 diabetes management, formulated by Hertz Pharma. It combines Linagliptin (5 mg) and Dapagliflozin (10 mg), two powerful antidiabetic agents that work together to improve blood sugar control. Linagliptin, a DPP-4 inhibitor, enhances insulin secretion and reduces glucose production, while Dapagliflozin, an SGLT2 inhibitor, promotes glucose excretion through urine. This dual mechanism helps achieve better glycemic control, making Linahert D5/10 an effective option for patients who need additional support beyond diet and exercise.
Detailed Description of Business Linahert D5/10 is especially beneficial for individuals who require a once-daily, weight-neutral therapy with a low risk of hypoglycemia. It can be taken alone or in combination with other diabetes medications, depending on individual needs. However, patients with severe kidney disease, a history of pancreatitis, or those at risk of dehydration should consult their healthcare provider before starting this medication. Regular monitoring of blood sugar levels, along with a balanced lifestyle, can further enhance the effectiveness of Linahert D5/10 in managing diabetes and preventing long-term complications.
